Notably, DCRGs showed a high mutation frequency in colorectal cancer and melanoma, with CTNNB1 having the highest mutation frequency in hepatobiliary cancer (23.7%) and uterine endometrioid carcinoma (20.8%) (Figure 5B). This evidence concerns the gene CTNNB1 and melanoma.